Please enable Javascript on your browser for a better experience.
The Bilirubin Direct Test measures conjugated bilirubin in the blood to assess liver function and bile duct health. Elevated levels may indicate hepatitis, cirrhosis, gallstones, or bile duct obstruction, while low levels are generally normal. Doctors order this test for patients with jaundice, fatigue, or suspected liver disease. Results help diagnose and monitor liver disorders, guide treatment decisions, and evaluate overall hepatic and biliary health.
The GLP-1 Cardiometabolic Safety & Optimization Panel includes 18 tests and 50 biomarkers to support provider-guided review of blood sugar, insulin resistance, pancreatic enzymes, liver and bile-flow markers, kidney and urine risk, inflammation, iron storage, muscle stress, magnesium status, and advanced cardiometabolic risk. Includes A1c, insulin, C-peptide, lipase, amylase, CMP, GGT, bilirubin, ApoB, Cardio IQ™ lipids, and hs-CRP.